Season 16 · Episode 24
S16 Ep24: Tumor Board: Translating HER2 and TROP2 Innovations to Transform NSCLC Care
OncLive® On Air · OncLive® On Air
March 11, 202630m 23s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this podcast, experts Jacob Sands, MD; Marina Chiara Garassino, MD; and Eric Singhi, MD; use realistic cases to explore key decision points in applying HER2- and TROP2-targeted therapies across the non–small cell lung cancer (NSCLC) continuum, including patient selection, sequencing, and toxicity management.